Progress in the clinical development of CX-2051, targeted at advanced colorectal cancer, with initial Phase 1a clinical data expected in the first half of 2025. CytomX maintains a strong financial ...
Great customer experience means nothing if your team is doing the heavy lifting behind broken systems — and eventually, that ...
CytomX Therapeutics has updated its pipeline priorities for 2025, highlighting its lead program, CX-2051, a first-in-class PROBODY ADC targeting EpCAM for advanced metastatic colorectal cancer, with ...
The Daniel Group, a leader in B2B customer experience, introduces the CX Institute, offering training and coaching to enhance CX programs. Leveraging insights from one million surveys, the initiative ...
In the world of seemingly identical customer experience (CX) programs, differentiation is the unsung hero that can set your company apart from the competition. Kantar asserts in its company blog that ...
In today’s competitive business landscape, customer experience (CX) has become a critical differentiator. Yet despite the intense focus on CX since 2020, this year saw a decline in average CX quality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results